VEGFA and age-related macular degeneration: Recently, the comparison of Age-Related Macular Degeneration Treatment Trials (CATT) revealed equivalent effects on visual acuity after 1 year of monthly injection of anti-VEGF antibodies in neovascular AMD [23].